We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
Cap. Flow
+$425M
Cap. Flow %
0.92%
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$128M
2
BKR icon
Baker Hughes
BKR
+$26.7M
3
IQV icon
IQVIA
IQV
+$14.5M
4
OKE icon
Oneok
OKE
+$14.3M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.2M

Sector Composition

Rank Sector Weight
1 Financials 16.64%
2 Technology 15.8%
3 Healthcare 13.57%
4 Industrials 10.87%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DE icon
126
Deere & Co
DE
$169B
$71.7M 0.16%
570,766
+29,971
+6% +$3.7M
ICE icon
127
Intercontinental Exchange
ICE
$84.1B
$71.4M 0.16%
1,039,493
+17,477
+2% +$1.15M
VLO icon
128
Valero Energy
VLO
$90.5B
$71M 0.15%
923,463
+32,161
+4% +$2.21M
ISRG icon
129
Intuitive Surgical
ISRG
$128B
$70.9M 0.15%
610,470
+22,509
+4% +$2.45M
ESRX
130
DELISTED
Express Scripts Holding Company
ESRX
$70.8M 0.15%
1,117,499
+21,990
+2% +$1.37M
COF icon
131
Capital One
COF
$127B
$70.4M 0.15%
831,163
+4,862
+0.6% +$401K
BDX icon
132
Becton Dickinson
BDX
$43.8B
$70.1M 0.15%
366,717
+10,056
+3% +$1.95M
HAL icon
133
Halliburton
HAL
$26.8B
$70.1M 0.15%
1,523,059
+13,050
+0.9% +$547K
SPGI icon
134
S&P Global
SPGI
$130B
$69.5M 0.15%
444,313
+5,593
+1% +$850K
PX
135
DELISTED
Praxair Inc
PX
$69.4M 0.15%
496,925
-37,553
-7% -$5.01M
PSA icon
136
Public Storage
PSA
$60.5B
$69.4M 0.15%
324,401
+10,359
+3% +$2.14M
BSX icon
137
Boston Scientific
BSX
$67.6B
$69.1M 0.15%
2,370,126
+56,189
+2% +$1.55M
NSC icon
138
Norfolk Southern
NSC
$77.1B
$68.8M 0.15%
519,921
-22,458
-4% -$2.73M
TRV icon
139
Travelers Companies
TRV
$81.4B
$67.9M 0.15%
554,181
+1,649
+0.3% +$206K
EBAY icon
140
eBay
EBAY
$50.3B
$67.8M 0.15%
1,763,910
+5,649
+0.3% +$205K
ALL icon
141
Allstate
ALL
$67.3B
$67.4M 0.15%
733,071
+10,795
+1% +$982K
ZTS icon
142
Zoetis
ZTS
$32.2B
$66.8M 0.15%
1,047,264
-18,231
-2% -$1.14M
TFC icon
143
Truist Financial
TFC
$63.7B
$66.4M 0.14%
1,415,505
+19,307
+1% +$888K
EQIX icon
144
Equinix
EQIX
$103B
$66.1M 0.14%
148,128
+953
+0.6% +$427K
AON icon
145
Aon
AON
$78.4B
$66M 0.14%
451,659
-229
-0.1% -$32K
VRTX icon
146
Vertex Pharmaceuticals
VRTX
$122B
$65M 0.14%
427,457
+6,137
+1% +$924K
PLD icon
147
Prologis
PLD
$137B
$64.5M 0.14%
1,015,848
+4,589
+0.5% +$283K
KMI icon
148
Kinder Morgan
KMI
$70.6B
$64.1M 0.14%
3,342,367
+41,297
+1% +$804K
ECL icon
149
Ecolab
ECL
$76.4B
$64.1M 0.14%
498,055
+3,716
+0.8% +$489K
JCI icon
150
Johnson Controls International
JCI
$87.5B
$63.7M 0.14%
1,581,452
-17,764
-1% -$719K

Similar funds

RhumbLine Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
  • RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
  • RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
  • RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
  • RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.